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The association between particulate air pollu-
tion and cardiovascular mortality rate and hos-
pitalization has been reported in epidemiologic
studies (Koken et al. 2003; Pope et al. 1999,
2004a). In most epidemiologic studies, partic-
ulate matter (PM) has been characterized as
the mass concentration of coarse particles with
aerodynamic diameters < 10 µm (PM10) and
fine particles with aerodynamic diameters
< 2.5 µm (PM2.5). The association appears to
be more evident as particle size gets smaller.
Schwartz et al. (1996) reported that the associ-
ation between PM and daily mortality rates
was more evident with exposure to PM2.5 than
to PM10. By examining the relationship
between air pollution and cardiopulmonary
health in elderly subjects with coronary heart
disease (CHD), de Hartog et al. (2003) showed
that PM2.5 had a greater association with some
cardiac symptoms than did PM10. Several
panel studies also demonstrated that decreased
heart rate variability (HRV) was separately
associated with either mass concentrations of
PM10 (Gold et al. 2000; Pope et al. 1999) and
PM2.5 (Creason et al. 2001; Gold et al. 2000;
Holguin et al. 2003; Liao et al. 1999; Magari
et al. 2001, 2002; Park et al. 2005; Pope et al.
2004b; Riediker et al. 2004) or number con-
centrations of submicrometer particles with a
size range of 0.02–1.0 µm (Chan et al. 2004).
However, it is still unknown whether the
association between PM and HRV differs by
particle size. To shed light on this question,
we used a panel of cardiac and hypertensive
patients to study which size fractions had
greater effects on HRV reduction among PM
with aerodynamic diameters between 0.3 µm
and 1.0 µm (PM0.3–1.0), between 1.0 µm and
2.5 µm (PM1.0–2.5), and between 2.5 µm and
10 µm (PM2.5–10).
Materials and Methods
Subjects. This panel study was designed to
monitor changes in PM mass concentrations
and HRV indices continuously and simultane-
ously in our study subjects from November
2002 through March 2003. There were
10 patients with CHD and 16 patients with
either prehypertension or hypertension in this
study. These patients were recruited from
the cardiology section, Department of Internal
Medicine, National Taiwan University
Hospital, and a community health center in
the Taipei metropolitan area (Hsin-Chuang
Health Center). All the CHD patients had his-
tory of angina pectoris and/or acute myocar-
dial infarction and had cardiac catheterized
and percutaneous transluminal coronary
angioplasty during the year before our panel
study. The prehypertensive/hypertensive
patients’ hypertension statuses were identiﬁed
by their annual health checkup at the health
center. Each subject’s sex, age, body mass
index (BMI), smoking status, and medical his-
tory were collected by a face-to-face inter-
viewed questionnaire. Each subject’s current
health status was obtained from medical charts
and examinations. Professionally trained nurses
performed sitting blood pressure measure-
ments for each patient with mercury sphygmo-
manometer. The criteria of Chobanian et al.
(2003) were used to define eight subjects as
hypertensive [systolic blood pressure (SBP)
≥ 140 mmHg or diastolic blood pressure
(DBP) ≥ 90 mmHg] and another eight sub-
jects as prehypertensive (SBP 120–139 mmHg
or DBP 80–89 mmHg). To reduce confound-
ing effects in this study, we excluded the fol-
lowing subjects from our recruitment: current
smokers; patients with hyperthyroidism, acute
cardiopulmonary failure, or paced cardiac
rhythm; and patients with current medications
of anticholinergics, beta-blockers, or antiar-
rhythmic agents. The ethics committee of the
National Taiwan University Hospital approved
this study. Written informed consent was
obtained from each participant before the study
embarked.
Continuous Holter monitoring and tape
processing. We performed continuous ambula-
tory electrocardiographic (ECG) monitoring
for each subject by using a PacerCorder
3-channel device (model 461A; Del Mar
Medical Systems LLC, Irvine, CA, USA) with
a sampling rate of 250 Hz (4 msec). We sent
ECG tapes to National Taiwan University
Hospital and used a Delmar Avionics model
Strata Scan 563 (Irvine, CA, USA) to do the
analysis. The ECG wave complex (QRS) was
classiﬁed as normal sinus rhythm, arterial or
ventricular premature beats, and noise by
comparing the adjacent QRS morphologic
features. The normal-to-normal (NN) inter-
vals were deduced from the adjacent normal
sinus beats. The NN interval time series were
then transferred to a personal computer and
postprocessed by a program written in Matlab
language (version 5.2; MathWorks Inc.,
Natick, MA, USA). The missing intervals of
the raw NN data were linearly interpolated
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It is still unknown whether the associations between particulate matter (PM) and heart rate
variability (HRV) differ by particle sizes with aerodynamic diameters between 0.3 µm and 1.0 µm
(PM0.3–1.0), between 1.0 µm and 2.5 µm (PM1.0–2.5), and between 2.5 µm and 10 µm (PM2.5–10).
We measured electrocardiographics and PM exposures in 10 patients with coronary heart disease
and 16 patients with either prehypertension or hypertension. The outcome variables were standard
deviation of all normal-to-normal (NN) intervals (SDNN), the square root of the mean of the sum
of the squares of differences between adjacent NN intervals (r-MSSD), low frequency (LF;
0.04–0.15 Hz), high frequency (HF; 0.15–0.40 Hz), and LF:HF ratio for HRV. The pollution vari-
ables were mass concentrations of PM0.3–1.0, PM1.0–2.5, and PM2.5–10. We used linear mixed-effects
models to examine the association between PM exposures and log10-transformed HRV indices,
adjusting for key personal and environmental attributes. We found that PM0.3–1.0 exposures at 1- to
4-hr moving averages were associated with SDNN and r-MSSD in both cardiac and hypertensive
patients. For an interquartile increase in PM0.3–1.0, there were 1.49–4.88% decreases in SDNN and
2.73–8.25% decreases in r-MSSD. PM0.3–1.0 exposures were also associated with decreases in LF
and HF for hypertensive patients at 1- to 3-hr moving averages except for cardiac patients at mov-
ing averages of 2 or 3 hr. By contrast, we found that HRV was not associated with either PM1.0–2.5
or PM2.5–10. HRV reduction in susceptible population was associated with PM0.3–1.0 but was not
associated with either PM1.0–2.5 or PM2.5–10. Key words: air pollution, autonomic system, epidemi-
ology, heart rate variability, particulate matter. Environ Health Perspect 113:1693–1697 (2005).
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method (Berger et al. 1986). Each 5-min seg-
ment of NN intervals was taken for HRV
analysis. The time domain measurements of
HRV were the SD of NN intervals (SDNN)
and the square root of the mean of the sum of
the squares of differences between adjacent
NN intervals (r-MSSD). The frequency-
domain measurements of HRV included low
frequency (LF; 0.04–0.15 Hz), high frequency
(HF; 0.15–0.40 Hz), and LF:HF ratio, which
were calculated by Welch’s averaged peri-
odogram of the NN intervals (Task Force
1996; Welch 1967). Fast Fourier transforma-
tion was performed to estimate power spectral
density. To avoid sleep effects on HRV, in our
data analysis we used approximately 16-hr
Holter measurements when the subjects were
awake between 0700 hr and 2300 hr. Each
subject provided approximately 192 successful
segments of 5-min HRV measurements for
further data analysis.
Personal exposure measurements. Personal
exposures to different sizes of PM were meas-
ured persistently by using a personal dust
monitor (DUST-check portable dust moni-
tor, model 1.108; Grimm Labortechnik Ltd.,
Ainring, Germany), which measured and
recorded 1-min mass concentrations of
PM0.3–1.0, PM2.5, PM10, as well as ambient
temperature and humidity. The DUST-check
portable dust monitor measured number con-
centrations by particle’s light-scattering prop-
erty and used a correction factor to derive
mass concentrations from reference aerosols
with a density of 0.92 and reﬂective index of
1.45. Collocated Rupprecht and Patashnick
1400a tapered element oscillating micro-
balance (TEOM) samplers (Thermo Electron
Corporation, East Greenbush, NY, USA)
were used to calibrate the mass concentrations
of PM10, PM2.5, and PM0.3–1.0 measured by
our DUST-check monitor before and after
study. Concurrent PM measurements by the
TEOM and the DUST-check monitor
showed good association between these two
monitors for three size fractions: PM10 (r2 =
0.90), PM2.5 (r2 = 0.91), and PM0.3–1.0 (r2 =
0.79). However, in the concurrent PM meas-
urements by two monitors, the DUST-check
monitor reported approximately 10, 15, and
30% more PM10, PM2.5, and PM0.3–1.0 mass
concentration, respectively, than did the
TEOM monitor.
To measure our patients’ personal PM
exposures, a technician carrying a DUST-
check monitor was asked to accompany each
subject from 0700 hr to 2300 hr. The sam-
pling inlet was kept at a distance of approxi-
mately 1–2 m away from each study subject,
depending on the subject’s activities. The tech-
nician also recorded subjects’ time–activity pat-
terns, such as walking, sitting, sleeping, dining,
and environmental tobacco smoke exposures
during daytime. After sampling, we obtained
mass concentrations of PM2.5–10 by subtracting
PM2.5 concentrations from PM10 concentra-
tions recorded in our monitors. We obtained
mass concentrations of PM1.0–2.5 by subtract-
ing PM0.3–1.0 concentrations from PM2.5 con-
centrations recorded in our monitors. By
summarizing 1-min PM2.5–10, PM1.0–2.5, and
PM0.3–1.0 concentrations to 1-hr moving
averages between 0700 hr and 2300 hr, we
obtained approximately 1,000 segments of PM
concentrations for each subject in our data
analysis.
Statistical analysis. We ﬁrst plotted PM by
HRV indices for each subject to determine if
there were observed associations between these
two variables, and if there were any outliers
that heavily inﬂuenced such associations. We
also used stepwise multiple regressions without
PM to determine key HRV-related personal
covariates with a p-value < 0.15. The covariates
that changed the estimated effect of PM by
> 10% were included in our ﬁnal models with
PM measurements. We then applied linear
mixed-effects regression models to examine the
association between PM and HRV for cardiac
and hypertensive patients separately and jointly
by running S-PLUS 2000 (MathSoft Inc.,
Cambridge, MA, USA). In our data analysis,
we treated each subject’s sex, age, BMI, and
hour of day as time-invariant variables, whereas
PM2.5–10, PM1.0–2.5, PM0.3–1.0, temperature,
humidity, and HRV were treated as time-
varying variables. The outcome variables were
SDNN, r-MSSD, LF, HF, and LF:HF ratio,
and the exposure variables were 1- to 4-hr
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Table 1. Basic characteristics of 26 study subjects.
Cardiac Hypertensive
Characteristic patients patients
Sex (n)
Female 1 11
Male 9 5
Age (years) 68.1 ± 3.6 68.8 ± 6.6
(61–72) (52–76)
BMI (kg/m2) 25.6 ± 4.8 24.4 ± 2.8
(19.5–34.7) (20.6–31.8)
Heart rate (beats/min) 79.6 ± 14.8 77.4 ± 11.9
(48.7–123.0) (47.9–114.8)
Health status (n)
CHD 10 0
Prehypertensiona 08
Hypertensionb 08
Values are mean ± SD (range) unless otherwise noted.
aPrehypertension: SBP 120–139 mmHg or DBP 80–89 mmHg.
bHypertension: SBP ≥ 140 mmHg or DBP ≥ 90 mmHg.
Table 2. Summary statistics for HRV indices, air pollution levels, and meteorologic variables (mean ± SD).
Variable Cardiac patients Hypertensive patients p-Valuea
Time-domain HRV
Log10 SDNN (msec) 1.53 ± 0.24 1.56 ± 0.21 < 0.0001
Range 0.71–2.01 0.73–2.10
No. 1,527 2,864
Log10 r-MSSD (msec) 0.97 ± 0.29 1.00 ± 0.27 0.0002
Range 0.39–1.83 0.40–1.86
No. 1,527 2,864
Frequency-domain HRV
Log10 LF (msec2) 2.15 ± 0.57 2.21 ± 0.49 0.0006
Range 0.05–3.91 0.38–4.16
No. 1,527 2,864
Log10 HF (msec2) 1.97 ± 0.65 2.07 ± 0.63 < 0.0001
Range 0.44–3.88 0.33–4.03
No. 1,527 2,864
LF:HF ratio 2.75 ± 3.33 2.14 ± 2.14 < 0.0001
Range 0.04–40.12 0.06–17.81
No. 1,527 2,864
Air pollutants
PM2.5–10 1-hr mean (µg/m3) 16.4 ± 10.7 14.0 ± 11.1 < 0.0001
Interquartile range 14.8 11.9
Range 0.7–59.6 0.3–66.5
No. 1,084 2,273
PM1.0–2.5 1-hr mean (µg/m3) 10.9 ± 8.5 12.6 ± 7.8 < 0.0001
Interquartile range 10.8 7.9
Range 0.9–48.8 0.5–62.8
No. 1,084 2,273
PM0.3–1.0 1-hr mean (µg/m3) 26.8 ± 25.9 37.2 ± 25.8 < 0.001
Interquartile range 28.3 27.2
Range 1.4–136.2 1.3–196.4
No. 1,084 2,273
Meteorologic variables
Temperature (°C) 25.0 ± 3.5 26.3 ± 3.6 < 0.0001
Range 18.4–31.4 17.6–33.0
No. 1,248 2,568
Relative humidity (%) 55.4 ± 8.5 57.0 ± 8.2 < 0.0001
Range 28.6–74.2 39.5–80.5
No. 1,248 2,568
aDifference between cardiac and hypertensive patients was tested by t-test.moving averages of PM2.5-10, PM1.0-2.5, and
PM0.3-1.0. All HRV indices except LF:HF ratio
were log10-transformed for further data analy-
sis. In our mixed-effects models, we treated
subject’s sex, age, BMI, hour of day, tempera-
ture, humidity, and PM as fixed effects and
each subject as a random effect. We used
smoothing spline in S-PLUS to plot outcome
variables against temperature and humidity to
determine whether their relation was linear or
nonlinear. Linear terms were chosen to control
temperature and humidity in our ﬁnal models
because our diagnostic plots showed a linear
relation between outcome variables and meteo-
rologic variables. Single-pollutant mixed-effects
models were used to determine pollution
effects for PM2.5–10, PM1.0–2.5, and PM0.3–1.0
separately. Multipollutant mixed-effects mod-
els were used to determine what size fractions
had greater pollution effects among PM2.5–10,
PM1.0–2.5, and PM0.3–1.0. The ﬁrst-order auto-
regressive model (AR1) was chosen to adjust
temporal autocorrelation of HRV meas-
urements because residuals plots showed that
AR1 was sufﬁcient to remove the autocorrela-
tion of the observed outcome series. Model
selections were based on the criteria of mini-
mizing Akaike’s information criterion (Akaike
1974). Pollution effects are expressed as per-
cent changes in HRV by interquartile changes
in PM concentrations.
Results
As shown in Table 1, the ages of our 26 study
subjects were 61–72 years among 10 cardiac
patients and 52–76 years among 16 prehyper-
tensive/hypertensive patients (the hypertensive
group). Their mean BMIs were 25.6 kg/m2 for
the cardiac patients and 24.4 kg/m2 for the
hypertensive group. Our study subjects’ HRV
indices, PM exposures, and meteorologic con-
ditions during the study period are summa-
rized in Table 2. The cardiac patients had
signiﬁcantly higher values of HRV indices than
did the hypertensive group. Moreover, the car-
diac patients had signiﬁcantly higher PM2.5–10
exposures but lower PM1.0–2.5 and PM0.3–1.0
exposures than did the hypertensive group. On
average, PM0.3–1.0 levels of 26.8 µg/m3 in the
cardiac patients and 37.2 µg/m3 in the hyper-
tensive group accounted for 49.5 and 58.3% of
PM10 mass concentrations in their respective
groups. The interquartile ranges of PM0.3–1.0
exposures spanned 28.3 µg/m3 for the cardiac
patients and 27.2 µg/m3 for the hypertensive
group. Pearson correlations between any two
combinations of PM2.5–10, PM1.0–2.5, and
PM0.3–1.0 showed moderate correlations
between PM0.3–1.0 and PM1.0–2.5 (r = 0.65)
and between PM1.0–2.5 and PM2.5–10 (r = 0.51)
only. Hourly temperature varied from 17.6°C
to 33.0°C, and hourly relative humidity varied
from 28.6 to 80.5% during the study period.
The associations between PM and time-
domain HRV indices estimated by mixed-
effects models are listed in Table 3. With sex,
age, BMI, hour of day, temperature, and
humidity being adjusted in our mixed-effects
models, PM0.3–1.0 exposures significantly
decreased SDNN and r-MSSD for both the
cardiac patients and the hypertensive group. By
contrast, PM2.5–10 and PM1.0–2.5 exposures
were not associated with SDNN or r-MSSD in
our study subjects. For cardiac patients,
interquartile increases in PM0.3–1.0 with 2- to
4-hr moving-average exposure were associated
with 2.87–4.88% decreases in SDNN. Their r-
MSSDs were decreased by 4.43–8.25% with
1- to 4-hr moving averages, respectively. For
the hypertensive group, interquartile increases
in PM0.3–1.0 with 1- to 4-hr moving averages
exposure accounted for about 1.49–1.79%
decreases in SDNN and 2.73–5.07% decreases
in r-MSSD. The greatest decreases in time-
domain HRV indices occurred with 3-hr mov-
ing averages for the cardiac patients and 4-hr
moving averages for the hypertensive group.
We examined the time course of PM exposures
only up to 4-hr moving averages because avail-
able data became substantially decreased for
calculating moving averages > 5 hr.
The associations between PM and fre-
quency-domain HRV indices by our mixed-
effects models are list in Table 4. For the
Particulate matter and heart rate variability
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Table 3. Percent changes (95% conﬁdence interval)a in time-domain HRV for interquartile increase in PM exposures estimated by mixed-effects models.
Cardiac patients Hypertensive patients
Exposure matrix PM2.5–10 PM1.0–2.5 PM0.3–1.0 PM2.5–10 PM1.0–2.5 PM0.3–1.0
SDNN
1-hr moving –1.73 (–3.53 to 0.08) –1.36 (–3.56 to 0.85) –1.50 (–3.45 to 0.45) –2.64 (–3.93 to 0.55) –2.39 (–5.40 to 0.62) –1.63* (–2.42 to –0.85)
2-hr moving –1.97 (–4.43 to 0.49) –2.40 (–5.13 to 0.32) –2.87* (–5.23 to –0.51) –3.51 (–7.87 to 0.85) –2.47 (–5.19 to 0.26) –1.75* (–2.74 to –0.76)
3-hr moving –1.70 (–4.39 to 0.98) –4.00 (–8.11 to 0.10) –4.88* (–7.79 to –1.97) –2.74 (–6.22 to 0.74) –1.83 (–5.17 to 1.52) –1.49* (–2.62 to –0.36)
4-hr moving –1.75 (–5.42 to 1.92) –4.50 (–9.52 to 0.52) –3.95* (–7.59 to –0.31) –2.49 (–6.13 to 1.15) –2.36 (–5.81 to 1.10) –1.79* (–2.97 to –0.61)
r-MSSD
1-hr moving –4.39 (–9.54 to 0.03) –4.39 (–8.89 to 0.10) –4.43* (–8.10 to –0.77) –2.53 (–5.10 to 0.04) –3.12 (–7.27 to 1.04) –2.73* (–4.39 to –1.08)
2-hr moving –4.36 (–8.99 to 0.27) –5.68 (–11.83 to 0.46) –6.91* (–11.41 to –2.40) –5.42 (–10.92 to 0.09) –4.33 (–9.91 to 1.24) –3.37* (–5.44 to –1.30)
3-hr moving –4.20 (–9.02 to 0.61) –6.30 (–12.73 to 0.14) –8.25* (–13.64 to –2.87) –3.15 (–6.32 to 0.03) –2.59 (–5.37 to 0.18) –3.36* (–5.65 to –1.07)
4-hr moving –2.70 (–9.24 to 3.84) –3.99 (–13.07 to 5.10) –4.94 (–11.60 to 1.72) –4.23 (–8.88, to 0.42) –5.17 (–10.79 to 0.44) –5.07* (–7.55 to –2.59)
aCoefﬁcients are expressed as percent changes for interquartile changes in PM exposures in models adjusting for sex, age, BMI, hour of day, temperature, and humidity. *p < 0.05.
Table 4. Percent changes (95% conﬁdence interval)a in frequency-domain HRV for interquartile increase in PM exposures estimated by mixed-effects models.
Cardiac patients Hypertensive patients
Exposure matrix PM2.5–10 PM1.0–2.5 PM0.3–1.0 PM2.5–10 PM1.0–2.5 PM0.3–1.0
LF
1-hr moving –1.85 (–4.33 to 0.62) –1.65 (–4.67 to 1.37) –1.91 (–4.51 to 0.69) –4.38 (–8.78 to 0.03) –3.72 (–7.84 to 0.30) –2.32* (–3.58 to –1.07)
2-hr moving –3.87 (–8.22 to 0.47) –3.10 (–6.84 to 0.64) –2.39 (–5.57 to 0.79) –5.23 (–10.95 to 0.05) –3.23 (–6.71 to 0.26) –1.86* (–3.46 to –0.25)
3-hr moving –2.98 (–6.65 to 0.69) –4.10 (–9.00 to 0.79) –3.83* (–8.29 to –0.36) –3.34 (–1.72 to 0.04) –1.75 (–3.87 to 0.37) –1.11 (–2.89 to 0.66)
4-hr moving –3.11 (–8.22 to 1.99) –4.96 (–11.97 to 2.06) –2.82 (–7.76 to 2.12) –2.96 (–6.63 to 0.71) –2.61 (–5.26 to 0.04) –1.53 (–3.43 to 0.37)
HF
1-hr moving –4.46 (–9.23 to 0.32) –3.66 (–8.25 to 0.93) –3.94 (–8.00 to 0.12) –4.92 (–9.94 to 0.10) –3.97 (–8.37 to 0.43) –3.10* (–4.95 to –1.25)
2-hr moving –4.41 (–9.55 to 0.72) –4.86 (–10.52 to 0.81) –5.28* (–10.20 to –0.36) –6.07 (–12.28 to 0.13) –4.28 (–9.15 to 0.60) –3.29* (–5.61 to –0.96)
3-hr moving –3.80 (–9.12 to 1.53) –3.31 (–10.36 to 3.74) –4.30 (–10.18 to 1.57) –1.94 (–5.44 to 1.55) –1.54 (–4.63 to 1.56) –2.84* (–5.41 to –0.26)
4-hr moving –3.39 (–10.62 to 3.84) –2.15 (–12.03 to 7.73) –2.38 (–9.49 to 4.74) –2.78 (–6.78 to 1.21) –3.55 (–9.04 to 1.94) –3.91 (–8.72 to 0.89)
LF:HF ratio
1-hr moving 8.45 (–3.48 to 20.38) 3.71 (–14.09 to 21.52) 5.75 (–4.06 to 15.56) 5.94 (–3.27 to 15.15) 3.43 (–8.77 to 15.63) 7.54 (–2.45 to 17.54)
2-hr moving 1.66 (–15.22 to 18.55) –6.84 (–29.89 to 16.21) 4.93 (–8.03 to 17.89) 10.70 (–2.19 to 23.59) 7.55 (–6.34 to 21.44) 10.16 (–1.28 to 21.59)
3-hr moving 11.69 (–7.27 to 30.64) –24.06 (–56.35 to 8.24) –9.11 (–27.76 to 9.55) –1.51 (–17.02 to 14.00) –3.32 (–21.22 to 14.57) 14.49 (–1.80 to 30.77)
4-hr moving 8.18 (–17.22 to 33.57) –47.72 (–96.30 to 1.17) –10.38 (–34.89 to 14.12) 3.41 (–16.91 to 23.74) 4.32 (–18.64 to 27.29) 16.58 (–0.75 to 33.91)
aCoefﬁcients are expressed as percent changes for interquartile changes in PM exposures in models adjusting for sex, age, BMI, hour of day, temperature, and humidity. *p < 0.05.cardiac patients, interquartile increases in
PM0.3–1.0 exposures signiﬁcantly decreased LF
by 3.83% with 3-hr moving averages and HF
by 5.28% with 2-hr moving averages. For the
hypertensive group, interquartile increases in
PM0.3–1.0 exposures decreased LF by 2.32%
and 1.86% with 1-hr and 2-hr moving aver-
ages, respectively. Their respective HF values
decreased by 2.84 and 3.29% by interquartile
increases in PM0.3–1.0 exposures with 1- to
3-hr moving averages. By contrast, PM2.5–10
and PM1.0–2.5 exposures were not associated
with LF or HF in our study subjects. No asso-
ciation was observed between PM of all three
size ranges and the LF:HF ratios in our study
subjects.
Because our study subjects are exposed to
PM10, PM2.5, and PM0.3–1.0 simultaneously
during the panel study, their exposures to
three size fractions of PM can be treated as
copollutants in our multipollutant models.
We found that PM0.3–1.0 effects on HRV
reduction in multipollutant models remained
as significant as those in the single-pollutant
models. By contrast, both PM2.5–10 and
PM1.0–2.5 were not associated with HRV
reduction in the multipollutant models.
Figure 1 lists one exemplary result of our mul-
tipollutant models, which shows the percent
reduction in HRV by PM2.5–10, PM1.0–2.5,
and PM0.3–1.0 using 3-hr moving averages of
these three PM fractions and all 26 subjects in
this study. As shown in Figure 1, our subjects’
SDNN, r-MSSD, and HF values were
decreased by about 3.16, 5.20, and 5.05% for
interquartile increases in 3-hr PM0.3–1.0 mov-
ing averages, respectively. To further deter-
mine whether disease status could modify the
association between PM and HRV, we com-
bined the data of cardiac and hypertensive
patients together and put them into our multi-
pollutant models with and without the disease
status as a variable in the models. We found
that the addition of disease status did not
signiﬁcantly change the coefﬁcients of PM in
our multipollutant models (data not shown).
Discussion
This is the ﬁrst study to report that PM0.3–1.0
measured in mass concentrations had effects on
reducing HRV among cardiac, prehyperten-
sive, and hypertensive patients. This study sup-
ports that PM0.3–1.0 had effects on decreasing
HRV indices in susceptible populations, as we
reported in a previous panel study using number
concentrations of submicrometer particles with
a size range of 0.02–1.0 µm (Chan et al. 2004).
One toxicologic study also reported that PM1.0
induced more production of interleukin-8,
lipid peroxidation, and tumor necrosis factor-α
in mouse macrophage RAW 264.7 cells than
did PM2.5–10 or PM1.0–2.5 (Huang et al. 2003).
The time courses of PM0.3–1.0 on HRV in
cardiac and hypertensive patients ranging
from 1 to 4 hr are in agreement with the ﬁnd-
ings of previous studies (Chan et al. 2004;
Gold et al. 2000; Magari et al. 2001, 2002).
These results indicate that PM0.3–1.0 can have
acute effects on cardiac autonomic function. It
has been reported that particles can affect both
sympathetic and parasympathetic nervous sys-
tems directly immediately after exposures
(Kodavanti et al. 2000; Lai and Kou 1998).
One possible pathway of such a mechanism is
the rapid passage of inhaled particles with
diameters < 100 nm into the blood circulation
(Nemmar et al. 2001, 2002). Under appropri-
ate circumstances, the activation of pulmonary
neural reflexes secondary to PM interactions
in autonomic tone may contribute to the
instability of vascular plaque or initiate cardiac
arrhythmias. Such a direct effect of PM repre-
sents a plausible explanation for the occur-
rence of rapid cardiovascular responses in 1-hr
moving average of PM0.3–1.0 exposure.
Another possible pathophysiologic link
between PM and less acute effects of cardio-
vascular responses is that inhaled particles may
exacerbate the autonomic function of the
heart via induced inflammation in lung and
proinflammatory cytokine expression in car-
diac macrophages (Stone and Godleski 1999).
Previous studies also reported that ultrafine
particles deposited in the alveoli might
increase blood coagulation via mechanisms of
pulmonary inﬂammation or direct action on
red blood cells (Donaldson et al. 2001; Peters
et al. 1997). This subsequently may contribute
to a systemic inﬂammatory state, which may
in turn be capable of activating hemostatic
pathways, impairing vascular function, and
causing atherosclerosis. Accordingly, we
believe particle-induced pulmonary inﬂamma-
tion can also indirectly result in HRV changes
or autonomic imbalance in the delayed phase
after PM0.3–1.0 exposures. This may explain
why HRV decrease reached its peak at 3–4 hr
after PM0.3–1.0 exposure in our study.
There is a growing recognition that auto-
nomic dysfunction plays an important role in
cardiovascular mortality. Autonomic nervous
system changes in HRV may increase the like-
lihood of sudden cardiac death (Task Force
1996). Decrease in HRV is also a strong pre-
dictor of cardiac mortality (La Rovere et al.
2003). Because the cardiac autonomic alter-
ation included both time-domain and fre-
quency-domain HRV indices in this study, we
believe that cardiovascular diseases may be
increased by PM0.3–1.0-induced decreases in
autonomic nervous system control or the
withdrawal of vagal activity (Bigger et al.
1992; Kleiger et al. 1987). However, it was
still unclear whether short-term and small
HRV ﬂuctuations caused by PM0.3–1.0 expo-
sures will eventually lead to cardiac deaths.
Because cardiac death is a consequence of a
complex interaction between the autonomic
nervous system, a myocardial substrate altered
in the course of disease processes, and myocar-
dial vulnerability leading to arrhythmogenic or
ischemic response, the presence of a single car-
diac alteration is usually not sufﬁcient to trig-
ger cardiac death (Zareba et al. 2001). Further
studies on environmental cardiology are needed
to determine whether the PM0.3–1.0-associated
HRV fluctuations observed in panel studies
have meaningful implications of cardiovascular
mortality clinically.
The following limitations of our study
design must be considered in explaining our
ﬁndings of PM0.3–1.0 effects on reducing HRV
in this study. First, the lack of information on
personal exposure to other air pollutants, such
as nitrogen dioxide, carbon monoxide, ozone,
and sulfur dioxide may confound the observed
associations between PM0.3–1.0 and HRV
indices. Because these air pollutants are usually
correlated with PM, they can bias our study
outcomes toward either positive or null results
(Zeger et al. 2000; Zeka and Schwartz 2004).
Therefore, we cannot entirely rule out the
effects of these air pollutants on reducing HRV
in this study. Second, the observed PM0.3–1.0
effects on HRV reduction may be due to dif-
ferences in particle components rather than
particle sizes. The lack of measuring chemical
and biologic components in our subjects’ PM
exposures prevents us from differentiating par-
ticle size from particle components in HRV
reduction in our study. Third, it is possible
that the DUST-check monitor may have been
turned off in high PM environments, such as
busy traffic zones, during the monitoring
period. More frequent calibrations of the
DUST-check monitor during the study could
have been more temporally supportive to vali-
date continued accuracy although a compari-
son with a collocated TEOM sample was made
to calibrate DUST-check monitors before
and after the study. Fourth, we cannot exclude
the confounding effects of respiration on the
Chuang et al.
1696 VOLUME 113 | NUMBER 12 | December 2005 • Environmental Health Perspectives
Figure 1. Estimated percent changes in HRV by
interquartile increase in PM0.3–1.0, PM1.0–2.5, and
PM2.5–10 exposures at 3-hr moving averages for 26
study subjects using multipollutant mixed-effects
models. Error bars indicate 95% confidence intervals.
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association between PM0.3–1.0 and HRV
because our subjects’ breathing patterns were
not measured in our study and the quantity,
periodicity, and timing of vagal cardiac outﬂow
are associated with variations of respiratory
depth and interval (Yasuma and Hayano
2004). Fifth, the technician’s presence may also
alter the subjects’ psychology and autonomic
system, and then alter their behaviors, including
breathing patterns and heart rates. Sixth, the
use of 5-min segments of NN intervals elimi-
nates the opportunity to evaluate HRV fre-
quencies > 5 min and to compare our results
against those ﬁndings using different averaging
times, such as 24-hr SDNN and standard devi-
ation of the averages of NN intervals in all 5-
min segments of the entire recording.
Therefore, our results did not preclude the ﬁnd-
ings of previous daily time-series studies on res-
piratory and cardiovascular mortality, which
have generally observed exposure lag structures
to be 1–5 or more days, because this study
examined time course only within 1 day.
Regardless of these limitations, we believe
our data generally support the conclusion
that PM0.3–1.0 is an environmental stressor,
which may contribute to the fluctuations of
HRV indices and trigger a cascade of events
by increasing autonomic function imbalance,
and may potentially lead to ischemia or fatal
arrhythmia in patients with underlying CHD,
prehypertension, or hypertension. Cardiac
patients together with hypertensive adults are
susceptible to PM0.3–1.0 and should be consid-
ered a high-risk target population in planning
future public health abatement measures
against PM0.3–1.0 pollution.
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